Detalhe da pesquisa
1.
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial.
Br J Cancer
; 130(2): 233-241, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996507
2.
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis.
Oncologist
; 26(4): 302-309, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336844
3.
The future of colorectal cancer research: an interview with Hans Schmoll.
Future Oncol
; 16(29): 2269-2271, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33074748
4.
Efficacy of a Bispecific Antibody Co-Targeting VEGFA and Ang-2 in Combination with Chemotherapy in a Chemoresistant Colorectal Carcinoma Xenograft Model.
Molecules
; 24(16)2019 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394786
5.
Multipotent mesenchymal stromal cells promote tumor growth in distinct colorectal cancer cells by a ß1-integrin-dependent mechanism.
Int J Cancer
; 138(4): 964-75, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26356035
6.
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
BMC Cancer
; 16: 699, 2016 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-27582078
7.
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial.
Lancet Oncol
; 16(13): 1355-69, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361971
8.
Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.
Oncologist
; 20(4): 450-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795636
9.
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Oncology
; 89(3): 137-42, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25791073
10.
Trans-sectoral care in patients with colorectal cancer: Protocol of the randomized controlled multi-center trial Supportive Cancer Care Networkers (SCAN).
BMC Cancer
; 15: 997, 2015 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26694748
11.
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Lancet Oncol
; 15(13): 1481-1492, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25456367
12.
Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II study.
Acta Oncol
; 53(3): 392-8, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24024696
13.
Pulmonary embolism in oncologic patients: frequency and embolus burden of symptomatic and unsuspected events.
Acta Radiol
; 55(1): 45-53, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23864061
14.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547438
15.
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.
Langenbecks Arch Surg
; 398(3): 347-75, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23456424
16.
Selective internal radiotherapy in advanced colorectal cancer: only for right-sided tumours?
Lancet Oncol
; 18(9): 1138-1139, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28781172
17.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.
Lancet Oncol
; 13(12): 1225-33, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23168362
18.
A systematic review of clinical trials of treatment regimens in HER2-amplified metastatic colorectal cancer.
Expert Rev Anticancer Ther
; 23(6): 633-641, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37127555
19.
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer.
Eur J Cancer
; 184: 137-150, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921494
20.
Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database.
Cancers (Basel)
; 15(16)2023 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37627145